Loading...

Follow Medindia.net | Latest Prostate Cancer News on Feedspot

Continue with Google
Continue with Facebook
or

Valid
Levels and distribution of syntaphilin within tumors may differentiate the subset of patients with prostate cancer who require more aggressive management and treatment, according to a new study in The American Journal of Pathology. For about 90 percent of men with prostate cancer, the cancer remains localized to the primary site, resulting in a five-year survival rate of almost 100 percent. Unfortunately, the remaining 10 percent of patients develop locally invasive and metastatic disease, ...
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Gene mutation among men with prostate cancer is associated with a reduced survival rate, according to the researchers at the Institute of cancer research, London, and The Royal Marsden NHS foundation trust. Men with mutations in the retinoblastoma gene in their tumours were more than three times as likely to die and nearly seven times as likely to relapse on standard treatments as those without the gene. The retinoblastoma gene, known as RB1, is so called because mutations in it cause a rare ...
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Men taking drug treatment for benign prostatic hyperplasia (BPH) experienced a delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease at the time of diagnosis, according to the researchers of the University of California San Diego School of Medicine. Men who took drugs that inhibit the enzyme 5 (and) #945;-reductase, known as 5-ARIs, were diagnosed with prostate cancer 3.6 years after the first signs of elevated levels of a protein called prostate-specific antigen (PSA) compared to 1....
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
One high dose of targeted radiation delivered directly to the tumor within a few minutes is found a safe and effective method for treating men with low-risk prostate cancer, according to a study presented at the ESTRO 38 conference. Radiotherapy traditionally involves a series of lower dose treatments that take place over several days or week. The new treatment is called high dose-rate brachytherapy and it delivers radiation via a set of tiny tubes. Researchers say this technique could offer ...
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Newly developed artificial intelligence (AI) system may help radiologists to detect prostate cancer effectively. The system, called bFocalNet/b, helps identify and predict the aggressiveness of the disease by evaluating magnetic resonance imaging (MRI) scans, and does so with nearly the same level of accuracy as experienced radiologists. FocalNet is an artificial neural network, which uses an algorithm that comprises more than a million trainable variables, according to researchers, ...
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
A new artificial intelligence (AI) system developed by UCLA researchers helps radiologists to improve their ability during prostate cancer diagnosis. The system, called FocalNet, helps identify and predict the aggressiveness of the disease evaluating magnetic resonance imaging, or MRI, scans, and it does so with nearly the same level of accuracy as experienced radiologists. In tests, FocalNet was 80.5 percent accurate in reading MRIs, while radiologists with at least 10 years of experience were 83....
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Majority of men struggle to understand the diagnosis and treatment of prostate cancer, reports a new study. The findings of the study are published in the journal iHealth Promotion Practice/i. Professors Joan Bottorff and John Oliffe are scientists with UBC's Men's Health Research Program. Together, while studying men's knowledge or literacy of prostate cancer, they realized many are in the dark when it comes to what they know about the disease. And, more importantly, what direction to take after a diagnosis....
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Men with enlarged prostates should continue to take commonly prescribed drugs called 5-alpha-reductase inhibitors, according to the research team led by the University of Edinburgh and UCL, but warn of additional health checks. 5-alpha-reductase inhibitors reduce the production of hormones called androgens and help to treat symptoms such as reduced urinary flow. Previous short-term studies had suggested these drugs, which include finasteride and dutasteride, might affect metabolism and could ...
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Prevalence or incidence of prostate cancer is going down and even stabilizing in some parts of the world, finds a new study. The United States has seen the biggest drop says the study. The results of this study are going to be presented at the AACR Annual Meeting 2019, March 29-April 3. Despite the trend toward declining or stabilizing rates, prostate cancer remains the second most commonly diagnosed cancer and the sixth leading cause of cancer death among men worldwide, said the study's lead ...
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
Men who receive androgen deprivation therapy after prostate gland removal are 80% more likely to suffer from depression than men who don't receive the hormonal treatment, said study. This leads researchers to suggest that patients receiving androgen deprivation therapy should be monitored for post-surgical depression. This is presented at the European Association of Urology congress in Barcelona. Increasingly doctors are becoming aware that for many men, a cancer diagnosis and treatment leads ...
Read Full Article

Read for later

Articles marked as Favorite are saved for later viewing.
close
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview